國發股份(600538.SH):大力拓展大健康和司法IVD領域
格隆匯5月15日丨國發股份(600538.SH)在業績説明會上表示,股價受宏觀經濟、行業政策、市場環境等多重因素影響。公司管理層密切關注公司股價波動情況,高度重視市值管理,公司將聚焦主業,持續做好經營管理,夯實發展基礎,不斷提升公司內在價值。同時,繼續圍繞公司長遠發展目標,創新思路,聚焦大健康發展戰略,以高科技發展為引領,以現有產業為基礎,以生物技術為核心,大力拓展大健康和司法IVD領域,尤其是根據今年新“國九條”的精神,着重實行內生與外延雙輪驅動,不斷開拓新局面,實現公司可持續、快速健康的跨越式發展。根據外部市場環境及監管導向,適時採取相應方式,提升市場信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.